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Abstract 
Background: The emergence of influenza A/H1N1/2009 is alarming. The severity of previous epidemics suggests that the susceptibility of 
the human population to H1N1 is directly proportional to the degree of changes in hemagglutinin/HA and neuraminidase/NA; therefore, 
H1N1/2009 and H1N1/2008 were analyzed for their sequence as well as structural divergence. 
Methodology: The structural and sequence divergence of H1N1/2009 and H1N1/2008 strains were analyzed by aligning HA and NA amino 
acid sequences by using ClustalW and ESyPred3D software. To determine the variations in sites of viral attachment to host cells, a 
comparison between amino acid sequences of HA and NA glycosylation sites was performed with NetNGlyc software. The antigenic 
divergence was executed by CTL epitope prediction method.   
Results: The amino acid homology levels of H1N1/2009 were 20.32% and 18.73% compared to H1N1/2008 for HA and NA genes, 
respectively.  In spite of the high variation in HA and NA amino acid composition, there was no significant difference in their structures. 
Antigenic analysis proposes that great antigenic differences exist between both the viral strains, but no addition of a new site of glycosylation 
was observed. 
Conclusions: To our knowledge, this is the first report suggesting that the circulating novel influenza virus A/H1N1/2009 attaches to the 
same glycosylation receptor sites as its predecessor influenza A/H1N1/2008 virus, but is antigenically different and may have the potential 
for initiating a significant pandemic. Our study may facilitate the development of better therapeutics and preventive strategies, as well as 
impart clues for novel H1N1 diagnostic and vaccine development. 
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Introduction 
A global pandemic of swine flu, a new strain of 
influenza A virus subtype H1N1, is currently 
underway. According to the World Health 
Organization (WHO), the epidemic started in early 
April and by September 20, 2009, over 318,925 cases 
with at least 3,917 deaths (CFR ~1.2%) were reported 
globally [1], including 10,233 cases and 315 deaths 
in India [2]. H1N1/2009 originated due to triple 
reassortment among North American swine (30.6%) 
and avian influenza (34.4%), human influenza 
(17.5%), and classical swine influenza virus (17.5%) 
[3]. Influenza A/H1N1 causes acute febrile 
respiratory tract infection by infecting epithelial 
respiratory cells. H1N1 continues to circulate and 
causes annual epidemics that kill approximately 0.25  
 
to 0.5 million people worldwide [4,5,6,7]. H1N1 has 
a unique capacity for genetic variation. 
Hemagglutinin (HA) and Neuraminidase (NA) are 
two surface glycoproteins of the virus and are the 
most important antigens for inducing protective 
immunity in the host [8]. The severity of previous 
epidemics suggests that susceptibility of the human 
population to H1N1 is directly proportional to the 
degree of change in HA and NA. Greater change 
results in lower herd immunity and higher 
susceptibility [9].  
We therefore analyzed HA and NA of the novel 
circulating influenza A/H1N1/2009 strain and 
compared it with its predecessor influenza 
A/H1N1/2008 virus for sequence variation as well as  
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structural and antigenic divergence for a better 
understanding of viral pathogenesis and antigenicity.  
 
Materials and Methods 
Sequences used in study 
For comparison between circulating 2009 and 
2008 strains, we used Influenza A/California/08/2009 
[submitted to NCBI by Shu et al. (29 April 2009) 
with accession numbers FJ971076 for HA and 
FJ966973 for NA] and Influenza A/USA/WRAMC-
1154048/2008 [submitted to NCBI by Houng et al. (1 
Feb 2008) with accession numbers CY038770 for 
HA and CY038772 for NA] H1N1 strains. These 
sequences were used because A/California/08/2009 
was the primary strain that led to the swine flu 2009 
pandemic and A/USA/WRAMC-1154048/2008 was 
its predecessor H1N1 isolated in 2008.  
 
Sequence divergence 
We analyzed the sequence divergence of 
H1N1/2009 and H1N1/2008 strains by aligning HA  
 
 
 
 
 
(Figure 1a) and NA (Figure 1b) amino acid 
sequences by using ClustalW 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html).  
 
Differentiation in glycosylation pattern 
To determine the variation in the sites of viral 
attachment to host cells, a comparison between 
amino acid sequences of HA and NA glycosylation 
sites was performed with NetNGlyc 1.0 software 
(http://www.cbs.dtu.dk/services/NetNGlyc/) (Table 
1).  
 
Antigenic vitiations 
The antigenic divergence between 2009 and 2008 
influenza A strains was executed by the CTL epitope 
prediction method.  The amino acid sequences of HA 
and NA were evaluated separately with CTLPred 
software (http://www.imtech.res.in/raghava/ctlpred/) 
using consensus approach. The predicted antigenic 
sites were compared for HA and NA, respectively 
(Table 2).  
Figure 1. ClustalW amino acid sequences alignment of HA (a) and NA (b) proteins of influenza H1N1/2009 and its 
predecessor H1N1/ 2008.  
 
The amino acid sequences of segment 4 of HA protein (a) and segment 6 of NA protein (b) are shown for the Influenza A/California/08/2009(H1N1) and A/District of Columbia/WRAMC-1154048/2008(H1N1) 
viruses as described earlier. Standard single-letter abbreviations for the amino acids are used. The collinear sequences were aligned by online use of ClustalW. Amino acid alignment exhibits non-conservative 
substitutions (“  ”), conservative substitutions (“:”) and semi-conservative substitutions (“.”). Conserved regions are represented as (“ ”). There are 20.32% differences in 566 positions.  
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Structural divergence 
To determine the structural divergence in HA and 
NA proteins, the amino acid sequences of HA and 
NA were independently analyzed with ESyPred3D 
software 
(http://www.fundp.ac.be/sciences/biologie/urbm/bioi
nfo/esypred/). Deviations between obtained structures 
were calculated (http://cl.sdsc.edu/ce/ce_align.html) 
considering high sequence similarity (Figure 2). 
Structures were visualized by RasMol 2.7.5. 
Secondary structures of both proteins from both 
isolates were compared. 
 
Results 
The most abrupt changes in antigenic specificity 
occurred through the HA and NA genes. Analysis 
exhibited an overall sequence homology of 79% in 
HA and 81% in NA among 2009 and 2008 viral 
strains. Our results revealed that the amino acid 
homology levels of H1N1/2009 were 20.32%  
 
 
 
 
 
 
 
(conservative 9.89%, semi-conservative 4.95% and 
non-conservative substitutions 5.48%) and 18.73% 
(conservative 9.15%, semi-conservative 5.32% and 
non-conservative 4.26%) compared to  H1N1/2008 
for HA (Figure 1a) and NA (Figure 1b), respectively. 
Secondary structure comparison suggests that the HA 
protein of H1N1/2009 (H-bonds: 314; Helices: 9; 
turns: 53; and strands: 44) and H1N1/2008 isolates 
(H-bonds: 317; Helices: 10; turns: 50; and strands: 
44) as well as the NA protein of H1N1/2009 (H-
bonds: 222; Helices: 3; turns: 47; and strands: 37) 
and H1N1/2008 isolates (H-bonds: 218; Helices: 2; 
turns: 45; and strands: 40) have variations. However, 
our structural comparison based on CE server 
analysis between H1N1/2009 and H1N1/2008 
suggests that in spite of high variations in HA and 
NA amino acid composition and differences in 
secondary structure, there was no significant 
difference in their structure (HA; Rmsd = 0.6 
angstrom and NA; Rmsd = 1.3 angstrom) (Figure 2).  
 
Figure 2. Structural comparison of HA and NA of 2009 and 2008 strains of influenza A/H1N1.  
 
Amino acid sequences were submitted to ESyPred3D software to derive structures for the HA and NA protein for both isolates A/California/08/2009(H1N1) and A/District of 
Columbia/WRAMC-1154048/2008(H1N1). The obtained PDB files were visualized by RasMol 2.7.5 and secondary structures are compared as shown in the figure. The obtained structure 
of both the proteins has been also shown in the figure.  Both the PDB files of 2009 and 2008 strains for HA and NA proteins were submitted to CE server for structural deviation. The 
structural alignment and the alignment characteristics are presented in the figure.  
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glycosylation in H1N1/2009 (Table 1); however, 
antigenic analysis proposes considerable antigenic 
differences between both the viral strains (Table 2). 
To our knowledge, this is the first report suggesting 
that the circulating virus H1N1 uses the same 
glycosylation sites for its attachment to receptors, but 
is antigenically different.  
 
Discussion 
 Considering the penetrance and global spread of 
swine flu, the World Health Organization has 
declared a world pandemic for the viral illness [10]. 
Sequence BLAST analysis of HA and NA genes of 
2009 viral strains reveals that the closest relatives of 
H1N1/2009 are A/Swine/Indiana/P12439/00 and 
A/Swine/England/195852/92 [9]. This observation 
suggests that somehow these viruses were transported 
from the United States of America and the United 
Kingdom to Mexico and transmitted to swine. The 
present report of the current outbreak suggests that 
H1N1/2009 is neither similar to the 1918 
pandemic influenza virus (18% different) nor to the 
1976 swine flu (12% different) [9,11]. Our amino 
acid sequence divergence analysis suggests a large 
variation in HA and NA proteins, but most of the 
substitutions are conservative and semi-conservative. 
We therefore have not observed any significant  
difference in the structure of HA and NA proteins, a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
finding which highlights the large structural 
flexibilities of HA and NA proteins. Contrary to 
H1N1/2009, the most successful pandemic influenza 
viruses have retained the core proteins of the virus 
and changed only HA and NA. 
There is no difference in glycosylation sites 
between the presently circulating virus and 
H1N1/2008. Glycosylation of HA and NA represent 
the characteristic of the pathogen to escape the host 
defense through co-evolution with the host and 
identification of the host receptor [12]. Our antigenic 
analysis shows that H1N1 strains of 2009 and 2008 
have large differences in antigenicity. This finding 
might be correlated with the large penetrance of 
H1N1/2009 because this strain has novel 
antigenicity; therefore, the human population lacks 
herd immunity [8]. High variation in amino acid 
sequences and the unique antigenicity of H1N1/2009 
suggest that although the virus infection currently is 
not severe, it has further pandemic potential [9,13]. 
Developing countries have higher risk of infection, 
circulation for a longer time period, and further 
pandemic evolution [13]. Co-infections during bouts 
of influenza might play a crucial role in the evolution 
of H1N1 and may cause the development of 
resistance to known antivirals.  Although the current 
strain of H1N1 has low virulence, mortality during 
infection has been observed [5].  
 
N-glycosylation 
Protein 
A/H1N1/2009 A/H1N1/2008 
Position Sequence Position Sequence 
HA 
28 NSTD 28 NSTD 
40 NVTV 40 NVTV 
104 NGTC 104 NGTC 
304 NTSL 303 NSSL 
498 NGTY 497 NGTY 
557 NGSL 556 NGSL 
  71 NCSV 
  176 NLSK 
  142 NHTV 
 
NA 
50 NQSV 44 NNTG 
58 NNTW 58 NSTW 
63 NQTY 63 NHTY 
68 NISN 70 NNTN 
88 NSSL 88 NSSL 
146 NGTI 146 NGTV 
235 NGSC 235 NGSC 
  434 NTTI 
Table 1. Comparison of N-glycosylation sites between HA and NA of 2009 and 2008 influenza A/H1N1 strains.  
 
The table shows a comparison of predicted N-glycosylation sites in amino acid sequences for segment 4 (HA) and segment 6 (NA) sequences of the isolate A/California/08/2009(H1N1) and 
A/District of Columbia/WRAMC-1154048/2008(H1N1). N-glycosylation potential (0.5) is taken as cutoff. 
 Red colour indicates the differences between N-glycosylation sites of isolates A/California/08/2009(H1N1) and A/District of Columbia/WRAMC-1154048/2008(H1N1) 
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The evolution of H1N1 2009 by triple 
reassortment from three different hosts and co-
infections with other influenza A viral strains is an 
alarming concern because it suggests that the virus is 
not only assorting in multiple hosts, but also getting 
more chances to reassort in humans. Along with 
antigenic shift and antigenic drift, H1N1 may evolve 
into a novel influenza A supervirus, which may be 
antigenenically unique. It may then transmit as well 
as infect and replicate in multiple hosts and may have 
resistance to known antivirals; therefore, future 
preparedness is mandatory. Long-term preventive 
measures should be considered along with short-term 
preventions [14]. Apart from viral factors, host 
factors may play an important role in influencing the 
dynamics of H1N1 infection [15]. Earlier serological 
evidence suggests that, due to immunity from prior 
exposure to the H2N2 influenza strains before 1900, 
the elderly were not affected severely in the 1957 
epidemic [16], but because the present influenza 
A/H1N1/2009 is a novel strain and has not been 
reported earlier, similar antigenic protection is not 
anticipated. The lack of pro-human adaptive 
molecular markers in the currently circulating strain 
suggests the involvement of new determinants 
responsible for transmission of the virus to human 
and low infection [8]. This virus, therefore, can be 
used to study the involvement of new determinants, 
which may help us to develop effective vaccines 
against lethal H1N1 strains.  
Collectively, our results highlight the need for 
studies on the evolution of H1N1 immunity, and for 
the first time, provide evidence that H1N1/2009 uses 
the same glycosylation sites as its predecessor 
H1N1/2008 and may have a potential to initiate a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
more seriously mortal pandemic, owing to its 
antigenic difference with H1N1/2008. Our study may  
facilitate the development of better therapeutics and 
preventive strategies. 
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